<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; radiotherapy</title>
	<atom:link href="http://oralcancernews.org/wp/tag/radiotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Mon, 06 Feb 2012 22:09:34 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Cisplatin aids survival of high-risk head and neck cancer</title>
		<link>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer/#comments</comments>
		<pubDate>Sat, 04 Feb 2012 02:44:50 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[extracapsular spread]]></category>
		<category><![CDATA[margins]]></category>
		<category><![CDATA[nodes]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12412</guid>
		<description><![CDATA[Source: www.oncologyreport.com Author: Miriam E. Tucker Adding chemotherapy to radiotherapy improved 10-year survival of resectable head and neck carcinomas among high-risk patients who had microscopically involved resection margins and/or extracapsular spread of disease – but not in high-risk patients who only had tumor in multiple lymph nodes. The findings come from a long-term update and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/cisplatin-aids-survival-of-high-risk-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Implications of the Oropharyngeal Cancer Epidemic</title>
		<link>http://oralcancernews.org/wp/implications-of-the-oropharyngeal-cancer-epidemic/</link>
		<comments>http://oralcancernews.org/wp/implications-of-the-oropharyngeal-cancer-epidemic/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 22:24:59 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[Centers for Disease Control and Prevention]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[oncologists]]></category>
		<category><![CDATA[oropharyngeal squamous cell carcinoma]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[Residual Tissues Repositories Program]]></category>
		<category><![CDATA[SEER]]></category>
		<category><![CDATA[US Food and Drug Administration]]></category>
		<category><![CDATA[vaccination]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12061</guid>
		<description><![CDATA[Source: Journal of Clinical Oncology Chaturvedi et al,1 analyzing specimens back to 1984, validate the long-held hypothesis that infection with human papillomavirus (HPV) has increased oropharyngeal squamous cell carcinoma (OPSCC) incidence in the US. They find the incidence of OPSCC in men—who have higher risks of both HPV-positive and HPV-negative OPSCC than women—similar to that [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/implications-of-the-oropharyngeal-cancer-epidemic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EU grants orphan drug status to BioAlliance Pharma&#8217;s clonidine Lauriad</title>
		<link>http://oralcancernews.org/wp/eu-grants-orphan-drug-status-to-bioalliance-pharmas-clonidine-lauriad/</link>
		<comments>http://oralcancernews.org/wp/eu-grants-orphan-drug-status-to-bioalliance-pharmas-clonidine-lauriad/#comments</comments>
		<pubDate>Sun, 06 Nov 2011 17:14:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[clonidine]]></category>
		<category><![CDATA[Lauriad]]></category>
		<category><![CDATA[oral mucositis]]></category>
		<category><![CDATA[orphan drug]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12018</guid>
		<description><![CDATA[Source: www.pharmabiz.com Author: staff European Commission has granted orphan drug designation to BioAlliance Pharma SA&#8217;s clonidine Lauriad for prevention of radiotherapy-induced oral mucositis in patients with head and neck cancer. Oral mucositis is a very frequent inflammation of the oral mucosa in head and neck cancer patients treated with radio- and chemotherapy (98,000 new patients [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/eu-grants-orphan-drug-status-to-bioalliance-pharmas-clonidine-lauriad/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy</title>
		<link>http://oralcancernews.org/wp/gp96-is-over-expressed-in-oral-cavity-cancer-and-is-a-poor-prognostic-indicator-for-patients-receiving-radiotherapy/</link>
		<comments>http://oralcancernews.org/wp/gp96-is-over-expressed-in-oral-cavity-cancer-and-is-a-poor-prognostic-indicator-for-patients-receiving-radiotherapy/#comments</comments>
		<pubDate>Sat, 15 Oct 2011 13:06:51 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[GP96]]></category>
		<category><![CDATA[locoregional]]></category>
		<category><![CDATA[metastasis]]></category>
		<category><![CDATA[radioresistance]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[survival]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11927</guid>
		<description><![CDATA[Source: http://7thspace.com Author: Chien-Yu Lin et al. Oral cavity cancers (ORC) are the most common cancers, and standard treatment is radical surgery with postoperative radiotherapy. However, locoregional failure remains a major problem, indicating radioresistance an important issue. Our previous work has shown that GP96 contributed to radioresistance in nasopharyngeal and oral cancer cell lines. In [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/gp96-is-over-expressed-in-oral-cavity-cancer-and-is-a-poor-prognostic-indicator-for-patients-receiving-radiotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study</title>
		<link>http://oralcancernews.org/wp/prevalence-and-treatment-management-of-oropharyngeal-candidiasis-in-cancer-patients-results-of-the-french-candidoscope-study/</link>
		<comments>http://oralcancernews.org/wp/prevalence-and-treatment-management-of-oropharyngeal-candidiasis-in-cancer-patients-results-of-the-french-candidoscope-study/#comments</comments>
		<pubDate>Tue, 20 Sep 2011 17:45:52 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[antifungal agents]]></category>
		<category><![CDATA[antineoplastic agents]]></category>
		<category><![CDATA[candidiasis]]></category>
		<category><![CDATA[epidemiology]]></category>
		<category><![CDATA[oral]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11814</guid>
		<description><![CDATA[Source: RedJournal.org Purpose The aim of this pharmaco-epidemiological study was to evaluate the prevalence of oropharyngeal candidiasis (OPC) in cancer patients treated with chemotherapy and/or radiotherapy. Methods and Materials Signs and symptoms of OPC were noted for all patients. Antifungal therapeutic management was recorded in OPC patients. Patients receiving local antifungal treatments were monitored until [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/prevalence-and-treatment-management-of-oropharyngeal-candidiasis-in-cancer-patients-results-of-the-french-candidoscope-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial</title>
		<link>http://oralcancernews.org/wp/palifermin-decreases-severe-oral-mucositis-of-patients-undergoing-postoperative-radiochemotherapy-for-head-and-neck-cancer-a-randomized-placebo-controlled-trial-2/</link>
		<comments>http://oralcancernews.org/wp/palifermin-decreases-severe-oral-mucositis-of-patients-undergoing-postoperative-radiochemotherapy-for-head-and-neck-cancer-a-randomized-placebo-controlled-trial-2/#comments</comments>
		<pubDate>Tue, 20 Sep 2011 17:11:59 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[Head and neck squamous cell carcinoma]]></category>
		<category><![CDATA[hematologic malignancies]]></category>
		<category><![CDATA[myelotoxic therapy]]></category>
		<category><![CDATA[oral mucositis]]></category>
		<category><![CDATA[palifermin]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[xerostomia]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11811</guid>
		<description><![CDATA[Source: OncologyStat.com TAKE-HOME MESSAGE This randomized, placebo-controlled trial found that weekly palifermin was associated with decreased incidence and duration of severe oral mucositis in patients undergoing postoperative chemoradiotherapy for head and neck cancer. SUMMARY OncologySTAT Editorial Team Combined chemoradiotherapy (CRT) offers improved outcomes after resection of locally advanced head and neck cancer but also increases [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/palifermin-decreases-severe-oral-mucositis-of-patients-undergoing-postoperative-radiochemotherapy-for-head-and-neck-cancer-a-randomized-placebo-controlled-trial-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Fighting cancer with scorpions?</title>
		<link>http://oralcancernews.org/wp/fighting-cancer-with-scorpions/</link>
		<comments>http://oralcancernews.org/wp/fighting-cancer-with-scorpions/#comments</comments>
		<pubDate>Fri, 09 Sep 2011 12:49:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[genetically engineered]]></category>
		<category><![CDATA[herpes virus]]></category>
		<category><![CDATA[HSV]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[viruses]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11761</guid>
		<description><![CDATA[Source: www.foxnews.com Author: Chris Kilham In the fight against cancer, scientists and medical researchers around the world are developing new medicines from seemingly unlikely natural substances. Recent reported developments involve the use of a bacteria found in soil, a poison from a highly toxic scorpion, and the virus that causes herpes. All three demonstrate novel [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fighting-cancer-with-scorpions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stroke and TIA risk doubled by radiotherapy, study finds</title>
		<link>http://oralcancernews.org/wp/stroke-and-tia-risk-doubled-by-radiotherapy-study-finds/</link>
		<comments>http://oralcancernews.org/wp/stroke-and-tia-risk-doubled-by-radiotherapy-study-finds/#comments</comments>
		<pubDate>Thu, 11 Aug 2011 14:21:03 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[carotid stenosis]]></category>
		<category><![CDATA[ischaemic stroke]]></category>
		<category><![CDATA[radiation vasculopathy]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[tia]]></category>
		<category><![CDATA[transient ischaemic attack]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11600</guid>
		<description><![CDATA[Source: www.imt.ie Author: Mary Anne Kenny The risk of transient ischaemic attack (TIA) or ischaemic stroke is at least doubled by head and neck radiotherapy, a problem increasing in urgency as patients survive their malignancies longer, an Australian review of the literature has concluded. Besides case reports, the reviewers found 77 studies of stroke, TIA [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/stroke-and-tia-risk-doubled-by-radiotherapy-study-finds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ischemic Stroke, Transient Ischemic Attack after Head &amp; Neck Radiotherapy</title>
		<link>http://oralcancernews.org/wp/ischemic-stroke-transient-ischemic-attack-after-head-neck-radiotherapy/</link>
		<comments>http://oralcancernews.org/wp/ischemic-stroke-transient-ischemic-attack-after-head-neck-radiotherapy/#comments</comments>
		<pubDate>Fri, 05 Aug 2011 19:47:55 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cerebrovascular disease]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[ischemic stroke]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer foundation]]></category>
		<category><![CDATA[radiation vasculopathy]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[tia]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11540</guid>
		<description><![CDATA[Source: AHA Journals Author: Chris Plummer, PhD; Robert D. Henderson, PhD; John D. O&#8217;Sullivan, MD; Stephen J. Read, PhD Abstract Background and Purpose—Cerebrovascular disease can complicate head and neck radiotherapy and result in transient ischemic attack and ischemic stroke. Although the incidence of radiation vasculopathy is predicted to rise with improvements in median cancer survival, [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/ischemic-stroke-transient-ischemic-attack-after-head-neck-radiotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV related oral cancers continue to increase in the US</title>
		<link>http://oralcancernews.org/wp/11216/</link>
		<comments>http://oralcancernews.org/wp/11216/#comments</comments>
		<pubDate>Mon, 06 Jun 2011 17:21:56 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Centers for Disease Control and Prevention]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[Dr. Gillison]]></category>
		<category><![CDATA[Epidemiology and End Results program]]></category>
		<category><![CDATA[genital warts]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV vaccine Gardasil]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[Merck & Co.]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[National Cancer Institute's Surveillance]]></category>
		<category><![CDATA[Ohio State Comprehensive Cancer Center]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11216</guid>
		<description><![CDATA[Source: International Medicine News CHICAGO – Human papillomavirus infection was firmly linked to the recent rise in oropharyngeal cancers in the United States, based on data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results program. If current trends continue, the incidence of HPV-related oral cancers will soon surpass that of cervical cancers, senior [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/11216/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>With HPV-related head and neck cancers rising, focus on treatment and vaccination</title>
		<link>http://oralcancernews.org/wp/with-hpv-related-head-and-neck-cancers-rising-focus-on-treatment-and-vaccination/</link>
		<comments>http://oralcancernews.org/wp/with-hpv-related-head-and-neck-cancers-rising-focus-on-treatment-and-vaccination/#comments</comments>
		<pubDate>Tue, 31 May 2011 21:23:46 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[drinking]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[robotic surgery]]></category>
		<category><![CDATA[sexual behavior]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[survival rate]]></category>
		<category><![CDATA[tongue]]></category>
		<category><![CDATA[tonsil]]></category>
		<category><![CDATA[vaccination]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11202</guid>
		<description><![CDATA[Source: blogs.wsj.com/health Author: Laura Landro A form of head and neck cancer associated with the sexually transmitted human papillomavirus is on the rise, especially in men, the WSJ reports. Fast-rising rates of oropharyngeal cancer — tumors in the tonsil and back-of-the-tongue area — have been linked to changes in sexual behavior that include the increased [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/with-hpv-related-head-and-neck-cancers-rising-focus-on-treatment-and-vaccination/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Head and Neck Cancers Linked to HPV are on the Rise</title>
		<link>http://oralcancernews.org/wp/head-and-neck-cancers-linked-to-hpv-are-on-the-rise/</link>
		<comments>http://oralcancernews.org/wp/head-and-neck-cancers-linked-to-hpv-are-on-the-rise/#comments</comments>
		<pubDate>Tue, 31 May 2011 18:00:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[anal cancer]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[hpv vaccine]]></category>
		<category><![CDATA[HPV-positive cancer]]></category>
		<category><![CDATA[Memorial Sloan Kettering Cancer Center]]></category>
		<category><![CDATA[Mt. Sinai Medical Center]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral sex]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[robotic surgery]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11193</guid>
		<description><![CDATA[Source: The Wall Street Journal A form of head and neck cancer associated with the sexually transmitted human papillomavirus is on the rise, especially in men, the WSJ reports. Fast-rising rates of oropharyngeal cancer — tumors in the tonsil and back-of-the-tongue area — have been linked to changes in sexual behavior that include the increased [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/head-and-neck-cancers-linked-to-hpv-are-on-the-rise/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinicians support the necessity of neck dissection because of high risk of recurrence in oral cancer patients</title>
		<link>http://oralcancernews.org/wp/clinicians-support-the-necessity-of-neck-dissection-because-of-high-risk-of-recurrence-in-oral-cancer-patients/</link>
		<comments>http://oralcancernews.org/wp/clinicians-support-the-necessity-of-neck-dissection-because-of-high-risk-of-recurrence-in-oral-cancer-patients/#comments</comments>
		<pubDate>Mon, 23 May 2011 19:23:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[brachytherapy]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[oral and maxillofacial surgery department]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer treatment]]></category>
		<category><![CDATA[oral tongue carcinoma]]></category>
		<category><![CDATA[radiotherapy]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11135</guid>
		<description><![CDATA[Source: HighWire Stanford University PURPOSE: In head and neck cancer, the most important prognostic factor is the presence or absence of neck metastasis. Although still debated in the published data regarding the &#8220;wait and see&#8221; policy for Stage T1-T2 oral cancer, a large number of clinicians support the necessity of neck dissection, especially in cases [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/clinicians-support-the-necessity-of-neck-dissection-because-of-high-risk-of-recurrence-in-oral-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Larynx preservation studies should consider treatment impact</title>
		<link>http://oralcancernews.org/wp/larynx-preservation-studies-should-consider-treatment-impact/</link>
		<comments>http://oralcancernews.org/wp/larynx-preservation-studies-should-consider-treatment-impact/#comments</comments>
		<pubDate>Sat, 21 May 2011 21:31:34 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[5-fluorouracil]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[cisplatin]]></category>
		<category><![CDATA[docetaxel]]></category>
		<category><![CDATA[dry mouth]]></category>
		<category><![CDATA[induction chemotherapy]]></category>
		<category><![CDATA[larynx]]></category>
		<category><![CDATA[quality of life]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[sticky saliva]]></category>
		<category><![CDATA[swallowing]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11122</guid>
		<description><![CDATA[Source: www.internalmedicinenews.com Author: Sara Freeman, Internal Medicine News Digital Network Almost one-quarter of patients who had been given induction chemotherapy before radiotherapy for head and neck cancer experienced long-term swallowing difficulties, with another 15% experiencing voice disabilities that correlated with the mobility of the vocal cords. Long-term data from the GORTEC (Groupe Oncologie Radiothérapie Tête [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/larynx-preservation-studies-should-consider-treatment-impact/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Two Elements Predict Swallowing Difficulties after Radiotherapy</title>
		<link>http://oralcancernews.org/wp/two-elements-predict-swallowing-difficulties-after-radiotherapy/</link>
		<comments>http://oralcancernews.org/wp/two-elements-predict-swallowing-difficulties-after-radiotherapy/#comments</comments>
		<pubDate>Wed, 18 May 2011 20:29:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[dysphagia]]></category>
		<category><![CDATA[glottic larynx]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[oral cavity]]></category>
		<category><![CDATA[pharynx]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11090</guid>
		<description><![CDATA[Source: International Medicine News LONDON – Nonglottic cancer and the presence of dysphagia before treatment are highly predictive for severe acute and late swallowing difficulties after radiotherapy for head and neck cancer, according to new data from the DAHANCA 6&#38;7 randomized trial. Patients with nonglottic cancer were more likely than those with other cancer types [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/two-elements-predict-swallowing-difficulties-after-radiotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

